Eculizumab therapy monitoring in patients with atypical HUS in clinical practice

被引：0
|
作者：
Fremeaux-Bacchi, Veronique [1 ,2 ]
Rosain, Jeremie [2 ]
Senant, Marie [2 ]
Martin, Paula Vierra [2 ]
Bordereau, Pauline [2 ]
Loirat, Chantal
机构：
[1] INSERM, Complement & Dis Team, CRC, UMRS 1138, Paris, France
[2] Hop Europeen Georges Pompidou, Serv Immunol Biol, Paris, France
来源：
MOLECULAR IMMUNOLOGY | 2015年 / 67卷 / 01期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
056
引用
收藏
页码：138 / 138
页数：1
相关论文
共 50 条
  • [1] Eculizumab in a case of hypocomplementaemic atypical HUS
    Camacho, J. A.
    Vila, A.
    Rodriguez de Cordoba, S.
    Lopez-Trascasa, M.
    Ramos, M.
    Vila, J.
    Gimenez, A.
    Rovira, C.
    PEDIATRIC NEPHROLOGY, 2011, 26 (08) : 1356 - 1356
  • [2] ATYPICAL HUS AND ECULIZUMAB TREATMENT: EXPERIENCE OF A TERTIARY CENTER
    Besbas, Nesrin
    Gulhan, Bora
    Ozen, Seza
    Topaloglu, Rezan
    Duzova, Ali
    Yildiz, Cigdem
    Ozaltin, Fatih
    PEDIATRIC NEPHROLOGY, 2012, 27 (09) : 1630 - 1630
  • [3] Pharmacokinetics and pharmacodynamics of eculizumab in individualized treatment of atypical HUS
    Volokhina, E.
    Wijnsma, K.
    Sweep, F.
    Bruggemann, R.
    Wetzels, J.
    Van de Kar, N.
    Van den Heuvel, L.
    PEDIATRIC NEPHROLOGY, 2016, 31 (10) : 1757 - 1757
  • [4] Safety and effectiveness of restricted eculizumab regimen in atypical HUS
    Wijnsma, K. L.
    Volokhina, E.
    Van Den Heuvel, L. P.
    Wetzels, J. F.
    Van De Kar, N. C.
    PEDIATRIC NEPHROLOGY, 2016, 31 (10) : 1883 - 1884
  • [5] THREE NOVEL PATHOGENIC MUTATIONS WITH PHENOTYPIC ATYPICAL HUS: SUBSEQUENT WITHDRAWAL OF ECULIZUMAB THERAPY
    Harkins, Victoria
    Ramage, Ian
    Reynolds, Ben
    PEDIATRIC NEPHROLOGY, 2017, 32 (09) : 1767 - 1767
  • [6] Successful rescue treatment for Atypical HUS recurrence in kidney transplant with plasma therapy and eculizumab
    Susana Adragna, Marta
    Cristina Lopez, Laura
    Margarita Briones, Liliana
    PEDIATRIC NEPHROLOGY, 2013, 28 (08) : 1572 - 1573
  • [7] ECULIZUMAB IMPROVES ATYPICAL HUS IN A PATIENT AFTER KIDNEY TRANSPLANTATION
    Gras, K.
    Koch, M.
    Nashan, B.
    Helmchen, U.
    Stahl, R. A. K.
    Thaiss, F.
    TRANSPLANT INTERNATIONAL, 2011, 24 : 37 - 38
  • [8] Eculizumab Dosing Regimen in Atypical HUS: Possibilities for Individualized Treatment
    Volokhina, E.
    Wijnsma, K.
    van der Molen, R.
    Roeleveld, N.
    van der Velden, T.
    Goertz, J.
    Sweep, F.
    Bruggemann, R. J.
    Wetzels, J.
    de Kar, N. van
    van den Heuvel, L.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 102 (04) : 671 - 678
  • [9] ECULIZUMAB DOSING REGIMEN IN ATYPICAL HUS: POSSIBILITIES FOR INDIVIDUALIZED TREATMENT
    Volokhina, Elena
    Wijnsma, Kioa
    Van der Molen, Renate
    Roeleveld, Nel
    Van der Velden, Thea
    Goertz, Joop
    Sweep, Fred
    Bruggemann, Roger
    Wetzels, Jack
    Van de Kar, Nicole
    Van den Heuvel, Lambertus
    PEDIATRIC NEPHROLOGY, 2017, 32 (09) : 1661 - 1662
  • [10] SUCCESSFUL TREATMENT OF ATYPICAL HUS IN A KIDNEY TRANSPLANT RECIPIENT WITH ECULIZUMAB AND BELATACEPT
    Zhang, Jia
    Hussain, Sabiha
    Nashar, Khaled
    Chopra, Bhavna
    Ko, Tina
    Kaplan, Robert
    Jasnosz, Katherine
    Sureshkumar, Kalathil
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2015, 65 (04) : A92 - A92
12345